POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION Monday, February 28, 2011   —  9:30 AM - 12:00 Noon Exhibit Hall Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... GYNECOLOGIC & OBSTETRICS PATHOLOGY Poster# Title and Authors Itinerary Planner 125 Increased CD4 Positive T-Cell Recruitment in Primary Chronic Vestibulitis Suggests Potential Disease Triggers. (1057) E Jacobson-Dunlop, C Leclair, M Goetsch, TK Morgan - OHSU, Portland; Oregon Health & Science University, Portland Add 126 Diagnostic Utility of p16INK4a in Cervical Biopsy Specimens from the Michoacan Cervical Cancer Screening Study II (MECCS II): Correlation with HPV Test Results and Cervical Cytology. (1031) KS Dyhdalo, A Chiesa-Vottero, L Nieves-Arriba, S Belinson, J Belinson, CN Booth, JA Brainard - Cleveland Clinic, OH; Preventive Oncology International, Inc., Cleveland Heights, OH Add 127 The Clinical Significance of "Squamous Intraepithelial Lesion (SIL) of Indeterminate Grade" as a Distinct Cytologic Category. (1149) D Wong, C Teschendorf, GY Lin, F Hasteh - University of CA, San Diego Add 128 Utility of P16, KI67 and HPV Test in Diagnosis of Cervical Intraepithelial Neoplasia and Atrophy in Women over 50 Years of Age with 3-7 Year Follow-Up. (1056) JA Jackson, U Kapur, P Rajan, A Salhadar, C Ersahin - Loyola University Medical Center, Maywood, IL Add 129 Invasive Endocervical Adenocarcinoma: Combining Depth and Pattern of Invasion for Better Identification of Patients with Lymph Node Metastases. (998) B Arville, E Silva, G Galliano, J Rutgers - Cedars-Sinai Medical Center, Los Angeles, CA; Long Beach Memorial Medical Center, CA Add 130 Rare Cervical Cancers: Immunohistochemistry and Correlation with HPV Infection Status by In-Situ Hybridization and Linear Array. (992) G Allo, M Tsao, M Rouzbahman, C Wei, S Kamel-Reid, G Rasty - University Health Network, Toronto, ON, Canada Add 131 Pathologic Abnormalities of Uteri Removed by Morcellation. A Review of 889 Cases. (1123) F Rosenblum, CN Otis - Baystate Medical Center/Tufts University Schoool of Medicine, Springfield, MA Add 132 Frequent Loss of Progesterone Response Competence in Isolated Non-Cycling Glands of Normal Secretory Endometrium. (1077) BE Lane, NM Monte, J Elvin, GL Mutter - Brigham and Women's Hospital, Boston, MA Add 133 Comparative Mutational Profiling of Multifocal Low Grade Endometrioid Adenocarcinomas Using Oncogene Point Mutation and Loss of Heterozygosity Analysis. (995) C Amador-Ortiz, SD Finkelstein, PH Huettner, JD Pfeifer - Washington University in St. Louis, MO; RedPath Integrated Pathology, Pittsburg, PA Add 134 10-Year Retrospective Study on High-Grade Endometrial Endometrioid Adenocarcinoma (HGEEA), FIGOIII: Morphology and Immunohistochemical Characterization. (1155) J Yoon, Z Zhang - Henry Ford Hospital, Detroit, MI Add 135 The Incidence of Microsatellite Instability in Synchronous Endometrial and Ovarian Endometrioid Adenocarcinomas: A Dilemma Revisited. (1129) SM Shiller, SE Kerr, JH Blommel, AM Rumilla, KC Halling, SN Thibodeau, F Medeiros - Mayo Clinic, Rochester, MN Add 136 Hedgehog Pathway Expression and Clinical Outcome in Endometrial Carcinoma (EC). (1105) W Mneimneh, MA Ashraf, CE Sheehan, JS Ross - Albany Medical College, NY Add 137 Overexpression of the Hedgehog Pathway Component Gli2 in Uterine Leiomyosarcoma (LMS) and STUMP: A Morphoproteomic Approach. (1027) S Dhingra, X Duan, RE Brown - University of Texas- Medical School, Houston Add 138 TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Ovarian High-Grade Serous Carcinoma. (1074) E Kuhn, RJ Kurman, RA Soslow, G Han, T-L Wang, I-M Shih - Johns Hopkins Medical Institutions, Baltimore, MD; Memorial Sloan Kettering Cancer Center, New York, NY Add 139 Immunologic Heterogeneity and Survival in Metastatic Serous Ovarian Carcinoma. (1052) IS Hagemann, P Patel, AR Hagemann, L-P Wang, G Coukos, MD Feldman - Univ of Pennsylvania, Philadelphia Add 140 Positive PTEN Expression Is Associated with Decreased Survival in Ovarian/Primary Peritoneal High Grade Serous Carcinoma. (1001) R Bakkar, D Urbauer, R Broaddus - MD Anderson Cancer Center, Houston, TX Add 141 Prevalence of DNA Mismatch Repair Protein Loss in 342 Primary Malignant Epithelial Ovarian Tumors. (1094) F-I Lu, A Pollett, P Ryan, A-M Mulligan, B Clarke, B Gilks - Vancouver General Hospital, BC, Canada; Mount Sinai Hospital, Toronto, ON, Canada; Toronto General Hospital, ON, Canada; St. Michael's Hospital, Toronto, ON, Canada; Bon Secours Hospital, Cork, Ireland Add 142 PAX8 and WT1 Are Superior to PAX2 and BRST2 in Distinguishing Mullerian Tract Tumors from Breast Carcinomas. (1028) MA DiMaio, AH Beck, KD Montgomery, RB West, TA Longacre, CS Kong - Stanford University, CA Add 143 Anti-FOXL2 Antibody Is a Sensitive and Specific Diagnostic Marker for Ovarian Sex Cord-Stromal Tumors. (988) OM Al-Agha, HF Huwait, C Chow, W Yang, JE Senz, SG Kalloger, DH Huntsman, R Young, CB Gilks - British Columbia Cancer Agency and Vancouver General Hospital, Vancouver, Canada; Massachusetts General Hospital, Boston Add 144 Sertoli-Leydig Cell Tumors: Just Variants of Granulosa Cell Tumors? . FOXL2, SOX9 and SRY Distinguish the Lineage of the Sex Cord Derivatives. (1008) R Buell-Gutbrod, M Ivanovic, O Fadare, J Steinmetz, A Montag, E Lengyel, K Gwin - University of Chicago, IL; Vanderbilt, Nashville Add 145 Microsatellite Marker Polymorphisms Provide Evidence for Germ Cell Origin of Mucinous Ovarian Carcinomas Associated with Concurrent Teratomas. (1066) SE Kerr, MJ McFalls, AB Flotte, KC Halling, DA Bell - Mayo Clinic, Rochester, MN Add 146 Ovarian Metastases of Pancreaticobiliary Tract Adenocarcinomas: Analysis of 35 Cases, with Emphasis on the Ability of Metastases To Simulate Primary Ovarian Mucinous Tumors. (1099) Z Meriden, AV Yemelyanova, R Vang, BM Ronnett - Johns Hopkins Medical Institutions, Baltimore, MD Add